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Aim: The aim of this study is to compare intraarticular steroid administration and steroid administration with hydraulic distention of
the glenohumeral joint in hemiplegic patients who had developed shoulder pain and limitation.
Materials and methods: The study consisted of 60 patients attending an inpatient rehabilitation program following a stroke. Each
patient had shoulder pain and shoulder limitations . The patients were divided into 3 groups consisting of 20 patients each, according
to their order of admission. Conventional physical treatment and rehabilitation (PTR) methods were applied to the patients in Group 1
(control group), conventional PTR and an intraarticular steroid were applied to Group 2, and conventional PTR, hydraulic distention,
and the steroid were applied to Group 3. The patients were evaluated according to joint range of motion (ROM), pain (Visual Analogue
Scale), and shoulder function before treatment, the first day of treatment, and 1 month after treatment began.
Results: ROM in all directions and function showed a statistically significant increase, along with a significant decrease in pain, 1 month
after treatment in all groups. The improvement in the steroid + hydraulic distention group (Group 3) was statistically significantly better
than in the steroid + PTR and control groups (P < 0.001).
Conclusion: We found a marked increase in the ROM in all directions, decreased pain, and better upper extremity function in hemiplegic
patients with shoulder pain and ROM limitation 1 month after the steroid administration + hydraulic distention of the shoulder joint.
This finding indicated that steroids together with hydraulic distention of the shoulder joint can be used as an inexpensive, easy, and
effective method in hemiplegic patients with shoulder pain and ROM limitation.
Key words: Hemiplegia, shoulder pain, adhesive capsulitis, hydrodilatation

1. Introduction
Shoulder pain and shoulder dysfunctions are one of the
main problems of hemiplegic patients. The incidence of
shoulder pain in hemiplegic patients varies between 5%
and 84%, and it is an important complication that affects
daily activities (1). Shoulder pain is common and occurs
within 6 months after stroke onset (2). Hemiplegia may
lead to pain and limitation of shoulder function due to
glenohumeral subluxation, adhesive capsulitis, complex
regional pain syndrome, spasticity, and subluxation (3).
Hemiplegic shoulder pain has been shown by clinical and
arthrographic evaluation to be complicated. Adhesive
capsulitis develops as a result of the chronic irritation,
damage, inflammation, and subluxation in the joint capsule
and leads to shoulder pain and limitation of motion with
the addition of spasticity (4).
Shoulder pain and limitation have an unfavorable
effect on rehabilitation results (1,3). The treatment of
this complication is important in the prognosis of the
* Correspondence: asudogn@yahoo.ca
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disorder. Treatment methods include positioning, using
a shoulder sling, joint range of motion (ROM) exercises,
functional electrical stimulation, physical treatment
and rehabilitation (PTR) procedures, local injections,
manipulations, and surgery as necessary, though there
is no consensus on the best treatment method at present
(5,6). Corticosteroids are frequently used for the shoulder
pain of hemiplegic patients in clinical practice (7–9).
Hydraulic distention has been shown to be effective in
adhesive capsulitis (10,11) but it has no application in the
treatment of the hemiplegic shoulder in practice. Studies
have shown that arthrographic saline hydraulic distention
and steroid injection in adhesive capsulitis are effective on
short-term pain, joint ROM, and function (12). We used
these data when planning our study.
The aim of this study was to compare the effectiveness
of conventional rehabilitation, intraarticular steroid
administration, and steroid + hydraulic distention
treatment on pain, joint ROM, and upper extremity
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function in hemiplegic patients who had developed
shoulder pain and joint motion limitation.
2. Materials and methods
A total of 60 patients who had shoulder pain and shoulder
limitation, chosen from patients who had been placed
in our rehabilitation program as an in-patient following
hemiplegia, were included in the study. Consent was
obtained from the hospital ethics committee before
starting the study. In-patients at our hospital between April
2008 and May 2009 who met the criteria were included in
the study. Patients who were unconscious, had bilateral
hemiplegia, or had experienced previous shoulder trauma
or shoulder surgery were excluded. The age, sex, dominant
hand, etiology, side affected, systemic diseases, and the
duration of the problem were recorded. The patients
were informed and written consent was obtained. The
patients were examined and upper extremity motor level
(Brunnstrom), spasticity (Ashworth Scale), joint ROM,
and upper extremity function level were evaluated with
the Functional Independence Measure (FIM) self-care
section (13–15). The Van Langenberghe classification was
used for grading shoulder subluxation (16). The pain level
was measured with a visual analogue scale (VAS) both at
rest and during activity. The patients were divided into
3 groups of 20 subjects each, depending on their order
of admission. The ROM, activity, and at-rest VAS and
FIM scores were evaluated on the first evaluation day
(1 day after admission), the next day, and 1 month later.
All evaluations were performed by the same physician.
The physician did not know whether the patients had
received an injection or not, making this a blind trial.
Patient injections were performed by another physician.
All 3 groups received PTR procedures (ROM exercises;
active, assisted exercises; and neurophysiological therapy
modality) from the physiotherapist while they were inpatients for 1 month.
Group 1’s patients received only PTR administration
(control group).
Group 2’s patients received an intraarticular steroid
and PTR administration.
Group 3’s patients received hydraulic distention in
addition to the steroid and PTR administration.
All injections were performed in a sterile manner using
a posterolateral approach (17). The posterolateral aspect
of the acromion was identified by palpation. The needle
was angled approximately 30° anterior to the coronal plane
and slightly superior to the transverse plane and then
inserted just below the angle of the acromion to a depth
of approximately 1.5 to 2 cm. The skin was prepped with
a povidone–iodine solution and then 0.5 mL Jetokain®
(2% lignocaine + 0.00125% epinephrine) was injected into
the skin and the soft tissues overlying the joint capsule.

This was followed by an intraarticular injection of 1.5 mL
Jetokain + 1 mL Celestone Chronodose® (betamethasone
disodium phosphate, 3.9 mg + betamethasone acetate, 3
mg). Group 3 underwent hydraulic distention with 20 mL
of saline solution after 1 mL Celestone Chronodose + 1.5
mL Jetokain.
2.1. Statistical analysis
Data analysis was performed with SPSS for Windows,
version 11.5. The Shapiro–Wilk test was used to determine
whether the distribution of continuous variables was close
to normal. Descriptive statistics were used to present
continuous variables as mean ± standard deviation and
median (minimum–maximum), while categorical changes
were presented as number of cases and percentages.
The significance of the differences between the
groups regarding the means was evaluated with one-way
ANOVA, while the Kruskal–Wallis test was used for the
median values. The post hoc Tukey test or nonparametric
multivariate comparison was used to determine the
responsible group(s) when one-way ANOVA or the
Kruskal–Wallis test found statistical significance. Pearson’s
chi-square or Fisher’s exact result chi-square test was used
to evaluate categorical variables.
The Friedman test was used to determine whether
the ROM and VAS levels within the groups showed a
significant change over time. When a significant statistical
result was found with the Friedman test, the Wilcoxon
signed-rank test was used to evaluate the significance of
the change in the self-care level before and after treatment
to determine the responsible follow-up times. The
independent t-test was used to determine whether there
was a significant change in the FIM level after treatment
compared to before treatment within groups.
P < 0.05 was considered statistically significant. The
Bonferroni correction was used to control type I error in
all possible multiple comparisons.
3. Results
There were 39 females (65%) and 21 males (35%) in the
study, with a mean age of 63.3 years (±5.7). Hypertension
was present in 86.6% of study patients, diabetes mellitus
in 30%, heart disease in 25%, asthma in 5%, and
hyperlipidemia in 18.3%. Additionally, hyperthyroidism,
hypothyroidism, chronic obstructive pulmonary disease
(COPD), anemia, depression, and dyspepsia were present
at lower rates. The hemiplegia was on the right side in 32
patients (53.3%) and the left side in 28 (46.6%). The type
of hemiplegia was thromboembolic in 43 patients (72%)
and hemorrhagic in 17 (28%). There was no significant
difference between the groups for age, sex, affected side, or
etiology (Table 1).
Table 2 presents the distribution of the study patients
by the degree of shoulder subluxation, ultrasonography
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Table 1. Distribution of hemiplegic patients to the groups by demographic characteristics.

Age

Group 1

Group 2

Group 3

P

65.2 ± 6.8

62.4 ± 8.2

62.4 ± 7.1

Sex

n

(%)

n

(%)

n

(%)

Female

13

(65)

16

(80)

10

(50)

Male

7

(35)

4

(20)

10

(50)

0.398
0.138

Etiology

0.210

Thromboembolic

17

(85)

12

(60)

14

(70)

Hemorrhagic

3

(15)

8

(40)

6

(30)

Side

0.648

Right

11

(55)

10

(50)

11

(55)

Left

9

(45)

10

(50)

9

(45)

Group 1 = control ; Group 2 = steroid; Group 3 = steroid + hydraulic distention.

Table 2. The shoulder subluxation degree, USG findings, and upper extremity tone of the study patients by group.
Group 1
(n = 20)

Group 2
(%)

(n = 20)

Group 3
(%)

(n = 20)

(%)

Degree of Subluxation

P
0.747

Normal

1

(5)

2

(10)

2

(10)

Grade I

8

(40)

7

(35)

6

(30)

Grade II

9

(45)

11

(55)

9

(45)

Grade III

2

(10)

0

(0)

2

(10)

Grade IV

0

(0)

0

(0)

1

(5)

USG

0.234

Normal

6

(30)

5

(25)

8

(40)

Tendinitis / Bursitis

14

(70)

15

(75)

12

(60)

Muscle Tone

0.037

Normal

8

(40)

2

(10)

2

(10)

0.028

Ash 1

6

(30)

12

(60)

5

(25)

0.048

Ash 2

5

(25)

4

(20)

12

(60)

0.015

Ash 3

0

(0)

1

(5)

1

(5)

0.437

Arm (Brunnstrom)
Group 1 = control; Group 2 = steroid; Group 3 = steroid + hydraulic distention.
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(USG) findings, and upper extremity tone. We found a
very high incidence of subluxation and tendinitis in our
patients, with the 3 groups having tendinitis or bursitis at
a rate of 77%. There was no difference between the groups
for the degree of subluxation and shoulder ultrasound
findings. The spasticity rate was 76%. The rates of spasticity
were higher and similar to each other in the injection
groups and lower in the control group. However, there was
a statistically significant difference between the groups
for upper extremity spasticity. There was no significant
difference between the groups for the arm Brunnstrom
staging of the patients.
Table 3 presents ROM measurements in all directions
for the patients and their comparisons. There was no
significant difference between the ROM measured in the
3 groups at first. Evaluation of the joint ROM for flexion
and abduction before and 24 h after treatment showed
no difference in the control group, while there was a
statistically significant improvement in both the steroid
and the steroid + hydraulic distention groups. Evaluation
of joint ROM for internal and external rotation showed a

statistically significant improvement only in the steroid +
hydraulic distention group’s patients after 24 h.
There was a statistically significant improvement in
all groups regarding joint ROM in all directions 1 month
after treatment when compared with pretreatment values
(Table 3). The ROM measurements in all directions of the
steroid + hydraulic distention group’s patients showed a
higher statistical significance level regarding the difference
between pretreatment, 1 day posttreatment, and 30 days
posttreatment measurements compared to the other
groups (P < 0.001).
Comparison of the pretreatment, 1 day posttreatment,
and 1 month posttreatment values for pain at rest and
during activity in all 3 groups showed no change in the
control group 1 day after treatment, while there was a
statistically significant improvement in the steroid and
steroid + hydraulic distention groups. Comparison
of shoulder pain at rest and during activity between
pretreatment and 1 month after treatment showed
statistically significant differences in all groups. The
decrease in the steroid + hydraulic distention group also

Table 3. Pretreatment and 1 day and 1 month posttreatment ROM measurements and comparisons.
Pretreatment

24 h later

1 month later

Group 1

122.5 (100–145)c

124.5 (100–145)b

152.5 (121.2–170)

Group 2

110 (100–125)

115 (105–130)

142.5 (135–166.2)

Group 3

95 (85–110)a,c

102.5 (90–120)b

160 (150–170)

Group 1

107.5 (96.2–138.7)c

109 (96.2–138.7)b

130 (120–163.7)

Group 2

100 (86.2–128.7)

105 (91.2–133.7)

135 (126.2–155)

Group 3

87.5 (72.5–103.7)a,c

97.5(82.5–113.7)b

152.5 (140–173.7)

Group 1

47.5 (40–55)c

48.5 (40–55)b

52.5 (45–60)

Group 2

40 (36.2–45)

45 (40–50)

52.5 (50–60)

Group 3

37.5 (35–40)a,c

45 (40–48.7)b

67.5 (61.2–70)

Group 1

45 (45–50)c

47.5 (45–50)b

52.5 (50–55)

Group 2

50 (41.2–55)

50 (45–58.7)

60 (50–65)

Group 3

37.5 (30–45)a,c

45 (31.2–50)b

65 (60–68.7)

Flexion

a,c

b

Abduction

a,c

b

Internal Rotation

c

b

External Rotation

c

b

Group 1 = control; Group 2 = steroid; Group 3 = steroid + hydraulic distention.
a
Statistically significant difference between pretreatment and 24 h posttreatment values (P < 0.001);
b
statistically significant difference between 24 h and 1 month posttreatment values (P < 0.001);
c
statistically significant difference between pretreatment and 1 month posttreatment values (P < 0.001).
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4. Discussion
Shoulder pain in hemiplegic patients can vary from mild
to severe and causes a reduced quality of life (18). There
are various opinions on the relation between shoulder
pain and shoulder pathology. The general opinion is
that subluxation is painless. However, the ischemia
in periarticular structures and strain in the shoulder
capsule due to the subluxation may cause shoulder pain
(4) and the real problem is the limitation in shoulder
joint ROM (especially passive external rotation) (19).
Another pathology in stroke patients is adhesive capsulitis.
Synovial capsule thickening, enhancement, and the
rotator cuff interval enhancement were more frequent in
hemiplegic shoulder pain group compared to contralateral
asymptomatic shoulders (20). It is reported that spasticity
of shoulder adductors, flexors, and internal rotators leads
to shoulder pain and limitation of external rotation.
In light of the literature above, it seems that hemiplegic
shoulder pain is complicated, with many factors acting
simultaneously. However, there is no consensus on the
best treatment method at present (5,6,21–23). We injected
a steroid in one experimental group and used steroid +
hydraulic distention in the other experimental group in
this study, postulating that decreased joint fluid played a

25
Pretreatment

One month later

20

Self-care

had higher statistical significance than in the other groups
(P < 0.001).
There was no difference in any group 1 day after
treatment for self-care motor FIM evaluation, while
a significant difference was present between the
pretreatment and 1 month posttreatment values (Table
4). However, comparison of the degree of change showed
a more statistically significant increase in self-care values
in the steroid + hydraulic distention group than either the
steroid + PTR or the control group (P < 0.001; Figure)
There was also an improvement in upper extremity
functions in addition to ROM and pain in the evaluation
1 month after treatment in all groups. However, the
improvements for all evaluations (pain, VAS, and FIM)
were statistically larger in the steroid + hydraulic distention
group.

15

10

5

0

Control

Steroid

Distention + Steroid

Figure. Changes between pretreatment and 1 month
posttreatment values in the patients in the 3 groups for FIM selfcare scores.

role in hemiplegic shoulder pain. We compared shoulder
pain, ROM, and upper extremity functions between the
group receiving conventional PTR only and those groups
receiving injections. All our patients had shoulder pain,
whether due to spasticity, shoulder joint inflammation,
or subluxation. There are many systematic reviews and
metaanalyses on the effectiveness of corticosteroid
injections administered for nonhemiplegic shoulder pain
(24,25). Corticosteroids are especially more effective than
nonsteroidal medications for rotator cuff tendinitis for up
to a 9-month period (24). Corticosteroids are frequently
used for the shoulder pain of hemiplegic patients in
clinical practice (7–9). Their effectiveness for pain, arm
function, and daily living activities has been investigated. A
recent retrospective case series reported that subacromial
corticosteroid injection is associated with significantly
reduced poststroke shoulder pain (7), but the evidence
regarding adhesive capsulitis was inconclusive. Snels et al.
administered intraarticular triamcinolone in their study
and found no statistically significant difference despite

Table 4. The pretreatment and 1 month posttreatment self-care FIM levels of the patients in the 3 groups.

Self-care FIM

Pretreatment

1 month later

(min-max)

Group 1

20.5

(16–29)

22

(17–30)

<0.001

Group 2

20

(17–29.5)

21

(19–30.7)

<0.001

Group 3

17

(14.2–21.5)

20

(18–23.7)

<0.001

Group 1 = control; Group 2 = steroid; Group 3 = steroid + hydraulic distention.
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observing improvement in amount of pain and amount
of function (8). In the current study, there was significant
improvement in both pain (rest and activity VAS) and
flexion–abduction in the corticosteroid and steroid +
hydraulic distention groups at 1 day after treatment in our
patients while the internal and external rotation difference
was not marked. However, there was more improvement
than in the control group in ROM measurements in all
directions and all parameters (VAS and self-care and FIM
values) at the 1-month evaluation.
We did not come across any study related to adhesive
capsulitis treatment in hemiplegic patients in the
literature. However, in nonhemiplegic patients, physical
therapy, intraarticular corticosteroid injections, closed
manipulation under anesthesia, arthroscopic capsular
release, and open surgical release are carried out, but
discussions on which of these options is the best one are
in progress (26).
Some reports state a positive effect of hydraulic
distention of the shoulder joint with high volumes
of fluids on decreasing pain and increasing function
(10–12). According to our systematic review, 5 studies
that investigated the effect of arthroscopic distention
in adhesive capsulitis are available. In these studies, it
is reported that application of a steroid along with the
saline distention is more effective on pain, function, and
ROM than a placebo, and that distention combined with
physical therapy has an influence only on function when
compared with the physical therapy alone. Furthermore,
the steroid combined with distention is more effective
when compared with the steroid alone. On the other
hand, the results of these studies may be questionable due
to the high risk of bias. According to the authors, although
they had a “sliver” level of evidence, the arthroscopic
distention and application of a steroid have short-term
effects on pain, function, and ROM with respect to
alternative treatments (12). In another study in which an
oral corticosteroid was compared with an intraarticular
corticosteroid 3 times, it was stated that the intraarticular
steroid was more effective in terms of pain, ROM, and
patient satisfaction (27).

Hydraulic distention, with or without steroids, has
been used for adhesive capsulitis only in nonhemiplegic
patients in the literature. We did not come across any
studies on hydraulic distention in the treatment of
adhesive capsulitis in hemiplegic patients. A study using
arthroscopy reported a positive correlation between joint
ROM and decreased joint fluid in hemiplegic patients
(4). We therefore felt that hydraulic distention could be
effective in hemiplegic patients, even if the pathogenesis
was different. The spasticity present in hemiplegic patients
in comparison to nonhemiplegic patients is a confusing
factor. One handicap of this study is the different spasticity
levels between the groups (spasticity was more common
in the injection groups). Steroid + hydraulic distention
treatment was more effective in our hemiplegic patients,
even though spasticity was present. The effect on ROM and
the pain appeared quickly (1 day later) and still continued
1 month later. The effect on function also continued 1
month later. Steroids have no known effect on adhesive
capsulitis and hydraulic distention has no known effect
on inflammation. However, we saw that they were more
effective when administered together. Steroid injection
+ hydraulic distention may have been effective on the
pain and ROM both by suppressing the inflammation
and increasing the joint volume, thereby decreasing
the pressure on the supraspinatus and periarticular soft
tissues. We cannot fully explain its effect on an extrinsic
factor causing shoulder pain such as spasticity. We believe
that the reason this was also effective in patients with
spasticity may be because decreased pain from treatment
interrupted the cycle of spasticity and pain. It may also be
due to the minimal effect of spasticity on ROM limitation.
These effects were limited in duration. Other handicaps of
this study are that the patients were not followed for a long
time and the long-term effect was not determined.
In conclusion, shoulder pain in hemiplegic patients
is complicated and multifactorial. Although unable
to explain it fully, we suggest that the use of a steroid +
hydraulic distention is a valuable method in addition to
conventional PTR applications for the shoulder pain of
hemiplegic patients, as it is easy to use, inexpensive, and
effective in a short time.
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